Trijardy XR 12.5 mg/1

Trijardy XR 12.5 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for blood sugar management. This extended-release tablet supports glycemic control in adults with type 2 diabetes. Learn about Trijardy XR uses, effects, and precautions.

Trijardy XR 12.5 mg/1 is designed to help manage blood sugar levels in adults with type 2 diabetes. This combination medication works by improving insulin sensitivity and reducing glucose absorption. People often ask, 'What is Trijardy XR used for?' It is typically prescribed as part of a broader diabetes management plan, including diet and exercise.

Common effects of Trijardy XR 12.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or hypoglycemia. These effects can vary and are not experienced by everyone.

Trijardy XR 12.5 mg/1 should be taken as directed by a healthcare provider. It is important to monitor blood sugar levels regularly and stay hydrated. This medication is not suitable for everyone, particularly those with severe kidney problems or a history of pancreatitis.

Trijardy XR 12.5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can also affect blood sugar levels and should be consumed with caution. Always inform your healthcare provider about all medications you are taking.